Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Pacific Edge Limited ( (PFGTF) ) has issued an update.
Pacific Edge Limited has announced the application for quotation of 190,319 ordinary fully paid foreign exempt securities on the ASX, with an issue date of October 7, 2025. This move is part of the company’s strategy to enhance its market presence and liquidity, potentially impacting its operational capabilities and offering new opportunities for stakeholders.
More about Pacific Edge Limited
Pacific Edge Limited operates in the biotechnology industry, focusing on the development and commercialization of diagnostic tests for the early detection and management of cancer. The company is known for its innovative cancer diagnostic solutions, aiming to provide non-invasive, accurate, and cost-effective testing options.
For an in-depth examination of PFGTF stock, go to TipRanks’ Overview page.